Diaceutics PLC (DXRX) — Financial Flexibility Index
Diaceutics PLC (DXRX) has a Financial Flexibility Index of 0.12x as of June 2025. Free cash flow of GBX855.00K (operating CF GBX800.00K minus capex GBX55.00K) represents 0% of total liabilities (GBX7.18 Million). Check Diaceutics PLC (DXRX) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Diaceutics PLC Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Diaceutics PLC across 9 annual periods. See Diaceutics PLC working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Diaceutics PLC (2016–2024)
Year-by-year free cash flow to debt coverage for Diaceutics PLC. For the full company profile including market capitalisation, see market cap of Diaceutics PLC.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.60x | GBX5.28 Million | GBX651.00K | GBX8.76 Million | ▼ -45.7% |
| 2023 | 1.11x | GBX6.17 Million | GBX1.31 Million | GBX5.56 Million | ▼ -36.1% |
| 2022 | 1.74x | GBX9.97 Million | GBX5.10 Million | GBX5.74 Million | ▲ +22.7% |
| 2021 | 1.41x | GBX6.17 Million | GBX570.00K | GBX4.36 Million | ▼ -29.1% |
| 2020 | 2.00x | GBX6.55 Million | GBX253.00K | GBX3.28 Million | ▲ +94.3% |
| 2019 | 1.03x | GBX2.30 Million | GBX-627.05K | GBX2.24 Million | ▲ +3364.8% |
| 2018 | 0.03x | GBX153.59K | GBX-954.04K | GBX5.18 Million | ▼ -94.1% |
| 2017 | 0.50x | GBX1.82 Million | GBX1.53 Million | GBX3.61 Million | ▲ +73.7% |
| 2016 | 0.29x | GBX703.05K | GBX674.01K | GBX2.43 Million | — |